Abstract | BACKGROUND: METHODS: Data from AAV patients aged ≥65 years were extracted from the French Vasculitis Study Group (FVSG) database and from a call for observation to FVSG members. Cox and Fine-Gray models were used to assess relapse risk, taking death into account either as a censoring or a competing event, respectively. RESULTS: The analysis included 219 patients aged ≥75 years (median 79) and 80 patients aged 65-75 years (median 70), of those 155 had GPA (52%), 136 MPA (45%), with 95 (32%) anti- proteinase 3 positivity and 179 (61%) anti- myeloperoxidase. Patients aged ≥75 years had a lower relapse risk in multivariate analysis (cause-specific hazards ratio [CSHR] 0.54, 95% CI [0.33-0.89], p = 0.016, Cox model; subdistribution hazard ratio [SHR] 0.46, 95% CI [0.29-0.74], p = 0.001, Fine-Gray model) after taking into account vasculitis type. Patients aged ≥75 years had a lower probability of being treated for remission maintenance with a combination of glucocorticoids and immunosuppressants (vs. glucocorticoids alone, HR 0.28, 95% CI [0.11-0.68], p = 0.005) after adjusting to Five Factor Score, although relapse-free survival was significantly longer when receiving such combination (CSHR 0.40, 95% [CI 0.24-0.67], p < 0.001). CONCLUSIONS: AAV patients ≥75 years have a lower relapse risk than patients aged 65-75 years despite a lower probability of having received maintenance therapy with a combination of glucocorticoids and immunosuppressants, but they still benefit from such treatment regimen.
|
Authors | Sara Thietart, Guillaume Beinse, Perrine Smets, Alexandre Karras, Carole Philipponnet, Jean-François Augusto, Khalil El Karoui, Rafik Mesbah, Dimitri Titeca-Beauport, Mohamed Hamidou, Pierre-Louis Carron, François Maurier, Karim Sacre, Pascal Cohen, Eric Liozon, Claire Blanchard-Delaunay, Alex Kostianovsky, Christian Pagnoux, Luc Mouthon, Loïc Guillevin, Benjamin Terrier, Xavier Puéchal, French Vasculitis Study Group |
Journal | Journal of internal medicine
(J Intern Med)
Vol. 291
Issue 3
Pg. 350-363
(03 2022)
ISSN: 1365-2796 [Electronic] England |
PMID | 34755398
(Publication Type: Journal Article, Multicenter Study)
|
Copyright | © 2021 The Association for the Publication of the Journal of Internal Medicine. |
Chemical References |
- Antibodies, Antineutrophil Cytoplasmic
|
Topics |
- Aged
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
(complications, drug therapy)
- Antibodies, Antineutrophil Cytoplasmic
- Cohort Studies
- Granulomatosis with Polyangiitis
(complications, drug therapy)
- Humans
- Recurrence
- Retrospective Studies
|